Medtronic Inc. to Pay $2.8 Million to Resolve False Claims Act Allegations Related to "SubQ Stimulation" Procedures
Medical device manufacturer Medtronic Inc. has agreed to pay the United States $2.8 million to resolve allegations under the False Claims Act that Medtronic caused certain physicians to submit false claims to federal health care programs for a medical procedure known as "SubQ stimulation," the Justice Department announced today. Medtronic Inc. is a medical technology company based in Minnesota.
- Date:February 6, 2015
- Agency:U.S. Department of Justice
- Criminal and Civil Actions